{"success":true,"data":{"pressRelease":{"id":"166446","rtpr_id":"nGNXcbMGrx-20261012","ticker":"SBC","exchange":"NASDAQ","all_tickers":["SBC"],"title":"SBC Medical to Present at Cantor Fitzgerald Hong Kong’s Inaugural Asia Longevity Forum","author":"Globe Newswire","published_at":"2026-10-12T13:00:00.873Z","article_body":"IRVINE, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings\nIncorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical\nServices Organization (MSO) providing management support across a wide range\nof healthcare fields, today announced that Yuya Yoshida, Director, CFO and COO\nof the Company and President and Representative Director of SBC AI Longevity\nInnovation Inc. (“SALI”), will speak at Cantor Fitzgerald Hong Kong’s\ninaugural Asia Longevity Forum (the “Forum”). In addition to the\npresentation, SBC Medical will hold one-on-one meetings with investors\nattending the Forum, and will conduct a non-deal roadshow (NDR) in Hong Kong\non October 28.\n\nEvent Details\nEvent: Cantor HK Asia Longevity Forum 2026 (inaugural edition), hosted by\nCantor Fitzgerald Hong Kong\nDate: Monday, October 26 – Tuesday, October 27, 2026\nVenue: The Murray Hotel, 22 Cotton Tree Drive, Central, Hong Kong\nDay 1 (October 26): Presentation by Mr. Yoshida\nThemes: The Longevity Economy; Healthy, Youthful Longevity for All\nGenerations; AI & Digital Health: From Innovation to Adoption; Building\nAsia’s Next Generation Healthcare System\nDay 2 (October 27): One-on-one meetings with investors\n\nThe Forum will bring together innovative thought leaders, business icons, and\nmore than 40 public and private companies to explore investment opportunities\nand the growing potential of the longevity market across Asia and beyond. Mr.\nYoshida will speak in the Forum’s keynote and panel sessions on October 26.\nFollowing the Forum, on October 28, SBC Medical will also conduct a non-deal\nroadshow (NDR) with investors in Hong Kong. SBC Medical is working on the\nlongevity field, and in July 2026 established SBC AI Longevity Innovation Inc.\n(SALI) to combine the clinical knowledge and data SBC Medical has accumulated\nacross its clinic network with AI technology, with the aim of creating new\nvalue in the longevity field. Mr. Yoshida leads this initiative as President\nand Representative Director of SALI. By sharing SBC Medical’s perspective at\nthe Forum, the Company aims to deepen its engagement with the growing\ncommunity of investors and industry leaders focused on Asia’s longevity\nmarket.\n\nThe presentation materials to be used at the Forum will be made available on\nthe Company’s IR website: https://ir.sbc-holdings.com/presentations/\n\nAbout SBC AI Longevity Innovation Inc.\nSBC AI Longevity Innovation Inc. is an operating company that combines the\nextensive knowledge and data SBC Medical Group has accumulated in clinical\nsettings with AI technology, with the aim of creating new value in the\nlongevity field and advancing clinic operations and the customer experience on\nan AI-native basis. Drawing on insights gained from actual clinic operations\nand customer touchpoints, the company will first focus on planning, developing\nand implementing products and services within the group. Following the “SBC\nAI Assistant,” it will move toward the practical application of further\nproducts that raise the level of day-to-day operations, including the “AI\nPreceptor” for staff training support, AI-enabled call center support, and\ndata solutions that advance longevity medicine. In the longer term, the\ncompany also intends to offer its development and operational expertise to\nother medical institutions and healthcare-related businesses.\n\nAddress: Shinjuku Island Tower 12F, 6-5-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo,\nJapan\nPresident and Representative Director: Yuya Yoshida\nEstablished: July 1, 2026\nBusiness: Planning and development of products and services in the AI and\nlongevity fields, and the provision and operational support of AI solutions\nfor medical institutions\nOfficial website: https://sbc-ai-longevity.com/\n\nAbout Cantor\nCantor, a premier global investment bank, is a part of the Cantor Fitzgerald\ngroup of companies. Founded in 1945, Cantor delivers unparalleled sector\nexpertise, innovative products, and tailored solutions across a broad range of\nfinancial services, including investment banking, capital markets, fixed\nincome and equities sales and trading, prime services, research, and asset\nmanagement. Headquartered in New York, the firm has more than 60 office\nlocations worldwide.\n\nAbout SBC Medical Group Holdings Incorporated\nSBC Medical is a Medical Services Organization providing management support\nacross a wide range of healthcare fields, including advanced aesthetic\nhealthcare, dermatology, orthopedics, fertility treatment, gynecology,\ndentistry, hair loss treatment (AGA), and ophthalmology. The Company manages a\ndiverse portfolio of clinic brands and is actively expanding its global\npresence, particularly in the United States and Asia, through both direct\noperations and medical tourism initiatives. In September 2024, the Company was\nlisted on Nasdaq, and in June 2025, it was selected for inclusion in the\nRussell 3000® Index, a broad benchmark of the U.S. equity market. Guided by\nits Group Purpose “Contributing to the well-being of people around the world\nthrough medical innovation,” SBC Medical Group Holdings Incorporated\ncontinues to provide safe, trusted, and high-quality medical services while\nfurther strengthening its international reputation for quality and trust in\nmedical care.\n\nFor more information, visit https://sbc-holdings.com\nFor more insights and updates from SBC Medical, follow us on LinkedIn.\n\nForward-Looking Statements\nThis press release contains forward-looking statements. Forward-looking\nstatements are not historical facts or statements of current conditions, but\ninstead represent only the Company’s beliefs regarding future events and\nperformance, many of which, by their nature, are inherently uncertain and\noutside of the Company’s control. These forward-looking statements reflect\nthe Company’s current views with respect to, among other things, the\nCompany’s plans and strategies for service expansion; growth in revenue and\nearnings; and business prospects. In some cases, forward-looking statements\ncan be identified by the use of words such as “may,” “should,”\n“expects,” “anticipates,” “contemplates,” “estimates,”\n“believes,” “plans,” “projected,” “predicts,” “potential,”\n“targets” or “hopes” or the negative of these or similar terms. The\nCompany cautions readers not to place undue reliance upon any forward-looking\nstatements, which are current only as of the date of this release and are\nsubject to various risks, uncertainties, assumptions, or changes in\ncircumstances that are difficult to predict or quantify. The forward-looking\nstatements are based on management’s current expectations and are not\nguarantees of future performance. The Company does not undertake or accept any\nobligation to release publicly any updates or revisions to any forward-looking\nstatements to reflect any change in its expectations or any change in events,\nconditions, or circumstances on which any such statement is based, except as\nrequired by law. Factors that may cause actual results to differ materially\nfrom current expectations may emerge from time to time, and it is not possible\nfor the Company to predict all of them; such factors include, among other\nthings, changes in global, regional, or local economic, business, competitive,\nmarket and regulatory conditions, and those listed under the heading “Risk\nFactors” and elsewhere in the Company’s filings with the U.S. Securities\nand Exchange Commission (the “SEC”), which are accessible on the SEC’s\nwebsite at www.sec.gov.\n\nContacts\nHikaru Fukui\nHead of IR Department\nE-mail: ir@sbc-holdings.com\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNXcbMGrx-20261012","title":"SBC Medical to Present at Cantor Fitzgerald Hong Kong’s Inaugural Asia Longevity Forum","author":"Globe Newswire","ticker":"SBC","created":"2026-10-12T13:00:00.873Z","tickers":["SBC"],"exchange":"NASDAQ","article_body":"IRVINE, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings\nIncorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical\nServices Organization (MSO) providing management support across a wide range\nof healthcare fields, today announced that Yuya Yoshida, Director, CFO and COO\nof the Company and President and Representative Director of SBC AI Longevity\nInnovation Inc. (“SALI”), will speak at Cantor Fitzgerald Hong Kong’s\ninaugural Asia Longevity Forum (the “Forum”). In addition to the\npresentation, SBC Medical will hold one-on-one meetings with investors\nattending the Forum, and will conduct a non-deal roadshow (NDR) in Hong Kong\non October 28.\n\nEvent Details\nEvent: Cantor HK Asia Longevity Forum 2026 (inaugural edition), hosted by\nCantor Fitzgerald Hong Kong\nDate: Monday, October 26 – Tuesday, October 27, 2026\nVenue: The Murray Hotel, 22 Cotton Tree Drive, Central, Hong Kong\nDay 1 (October 26): Presentation by Mr. Yoshida\nThemes: The Longevity Economy; Healthy, Youthful Longevity for All\nGenerations; AI & Digital Health: From Innovation to Adoption; Building\nAsia’s Next Generation Healthcare System\nDay 2 (October 27): One-on-one meetings with investors\n\nThe Forum will bring together innovative thought leaders, business icons, and\nmore than 40 public and private companies to explore investment opportunities\nand the growing potential of the longevity market across Asia and beyond. Mr.\nYoshida will speak in the Forum’s keynote and panel sessions on October 26.\nFollowing the Forum, on October 28, SBC Medical will also conduct a non-deal\nroadshow (NDR) with investors in Hong Kong. SBC Medical is working on the\nlongevity field, and in July 2026 established SBC AI Longevity Innovation Inc.\n(SALI) to combine the clinical knowledge and data SBC Medical has accumulated\nacross its clinic network with AI technology, with the aim of creating new\nvalue in the longevity field. Mr. Yoshida leads this initiative as President\nand Representative Director of SALI. By sharing SBC Medical’s perspective at\nthe Forum, the Company aims to deepen its engagement with the growing\ncommunity of investors and industry leaders focused on Asia’s longevity\nmarket.\n\nThe presentation materials to be used at the Forum will be made available on\nthe Company’s IR website: https://ir.sbc-holdings.com/presentations/\n\nAbout SBC AI Longevity Innovation Inc.\nSBC AI Longevity Innovation Inc. is an operating company that combines the\nextensive knowledge and data SBC Medical Group has accumulated in clinical\nsettings with AI technology, with the aim of creating new value in the\nlongevity field and advancing clinic operations and the customer experience on\nan AI-native basis. Drawing on insights gained from actual clinic operations\nand customer touchpoints, the company will first focus on planning, developing\nand implementing products and services within the group. Following the “SBC\nAI Assistant,” it will move toward the practical application of further\nproducts that raise the level of day-to-day operations, including the “AI\nPreceptor” for staff training support, AI-enabled call center support, and\ndata solutions that advance longevity medicine. In the longer term, the\ncompany also intends to offer its development and operational expertise to\nother medical institutions and healthcare-related businesses.\n\nAddress: Shinjuku Island Tower 12F, 6-5-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo,\nJapan\nPresident and Representative Director: Yuya Yoshida\nEstablished: July 1, 2026\nBusiness: Planning and development of products and services in the AI and\nlongevity fields, and the provision and operational support of AI solutions\nfor medical institutions\nOfficial website: https://sbc-ai-longevity.com/\n\nAbout Cantor\nCantor, a premier global investment bank, is a part of the Cantor Fitzgerald\ngroup of companies. Founded in 1945, Cantor delivers unparalleled sector\nexpertise, innovative products, and tailored solutions across a broad range of\nfinancial services, including investment banking, capital markets, fixed\nincome and equities sales and trading, prime services, research, and asset\nmanagement. Headquartered in New York, the firm has more than 60 office\nlocations worldwide.\n\nAbout SBC Medical Group Holdings Incorporated\nSBC Medical is a Medical Services Organization providing management support\nacross a wide range of healthcare fields, including advanced aesthetic\nhealthcare, dermatology, orthopedics, fertility treatment, gynecology,\ndentistry, hair loss treatment (AGA), and ophthalmology. The Company manages a\ndiverse portfolio of clinic brands and is actively expanding its global\npresence, particularly in the United States and Asia, through both direct\noperations and medical tourism initiatives. In September 2024, the Company was\nlisted on Nasdaq, and in June 2025, it was selected for inclusion in the\nRussell 3000® Index, a broad benchmark of the U.S. equity market. Guided by\nits Group Purpose “Contributing to the well-being of people around the world\nthrough medical innovation,” SBC Medical Group Holdings Incorporated\ncontinues to provide safe, trusted, and high-quality medical services while\nfurther strengthening its international reputation for quality and trust in\nmedical care.\n\nFor more information, visit https://sbc-holdings.com\nFor more insights and updates from SBC Medical, follow us on LinkedIn.\n\nForward-Looking Statements\nThis press release contains forward-looking statements. Forward-looking\nstatements are not historical facts or statements of current conditions, but\ninstead represent only the Company’s beliefs regarding future events and\nperformance, many of which, by their nature, are inherently uncertain and\noutside of the Company’s control. These forward-looking statements reflect\nthe Company’s current views with respect to, among other things, the\nCompany’s plans and strategies for service expansion; growth in revenue and\nearnings; and business prospects. In some cases, forward-looking statements\ncan be identified by the use of words such as “may,” “should,”\n“expects,” “anticipates,” “contemplates,” “estimates,”\n“believes,” “plans,” “projected,” “predicts,” “potential,”\n“targets” or “hopes” or the negative of these or similar terms. The\nCompany cautions readers not to place undue reliance upon any forward-looking\nstatements, which are current only as of the date of this release and are\nsubject to various risks, uncertainties, assumptions, or changes in\ncircumstances that are difficult to predict or quantify. The forward-looking\nstatements are based on management’s current expectations and are not\nguarantees of future performance. The Company does not undertake or accept any\nobligation to release publicly any updates or revisions to any forward-looking\nstatements to reflect any change in its expectations or any change in events,\nconditions, or circumstances on which any such statement is based, except as\nrequired by law. Factors that may cause actual results to differ materially\nfrom current expectations may emerge from time to time, and it is not possible\nfor the Company to predict all of them; such factors include, among other\nthings, changes in global, regional, or local economic, business, competitive,\nmarket and regulatory conditions, and those listed under the heading “Risk\nFactors” and elsewhere in the Company’s filings with the U.S. Securities\nand Exchange Commission (the “SEC”), which are accessible on the SEC’s\nwebsite at www.sec.gov.\n\nContacts\nHikaru Fukui\nHead of IR Department\nE-mail: ir@sbc-holdings.com\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-10-12T13:00:01.253295709Z","server_sent_at_ms":1791810001253},"received_at":"2026-10-12T13:00:01.306Z","source_url":null},"analysis":{"id":"154791","press_release_id":"166446","analysis_json":{"industry":{"label":"Health Care Providers & Services","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"SBC Medical announced that CFO/COO Yuya Yoshida will present at Cantor Fitzgerald Hong Kong's inaugural Asia Longevity Forum on October 26-27, 2026, followed by one-on-one investor meetings.\n\nThe company will also conduct a non-deal roadshow in Hong Kong on October 28 and will post presentation materials to its IR website.\n\nThe appearance spotlights SALI, the AI-and-longevity subsidiary established in July 2026 to apply SBC's clinical data to AI products, but the release contains no new financial or operational disclosures.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine investor-conference/roadshow notice -- suppress or archive for IR calendar."},"keyFigures":{"customDimensions":{"ndr_date":"October 28, 2026","forum_companies":"more than 40 public and private companies"}},"quotedText":"SBC Medical will hold one-on-one meetings with investors attending the Forum, and will conduct a non-deal roadshow (NDR) in Hong Kong on October 28.","namedEntities":{"people":[{"name":"Yuya Yoshida","role":"Director, CFO and COO of SBC Medical; President of SBC AI Longevity Innovation Inc."},{"name":"Hikaru Fukui","role":"Head of IR Department"}],"products":["SBC AI Assistant","AI Preceptor"],"companies":[{"name":"SBC Medical Group Holdings Incorporated","ticker":"SBC","relationship":"filer"},{"name":"SBC AI Longevity Innovation Inc.","relationship":"subsidiary"},{"name":"Cantor Fitzgerald Hong Kong","relationship":"forum host"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine investor-conference appearance and non-deal roadshow announcement with no new financial, clinical, or strategic information disclosed."},"tickerRelevance":{"others":[],"primary":"SBC"},"globalImportance":8,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"conference-appearance-notice","issuerAuthored":true}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"SBC Medical announced that CFO/COO Yuya Yoshida will present at Cantor Fitzgerald Hong Kong's inaugural Asia Longevity Forum on October 26-27, 2026, followed by one-on-one investor meetings.\n\nThe company will also conduct a non-deal roadshow in Hong Kong on October 28 and will post presentation materials to its IR website.\n\nThe appearance spotlights SALI, the AI-and-longevity subsidiary established in July 2026 to apply SBC's clinical data to AI products, but the release contains no new financial or operational disclosures.","key_figures":{"customDimensions":{"ndr_date":"October 28, 2026","forum_companies":"more than 40 public and private companies"}},"named_entities":{"people":[{"name":"Yuya Yoshida","role":"Director, CFO and COO of SBC Medical; President of SBC AI Longevity Innovation Inc."},{"name":"Hikaru Fukui","role":"Head of IR Department"}],"products":["SBC AI Assistant","AI Preceptor"],"companies":[{"name":"SBC Medical Group Holdings Incorporated","ticker":"SBC","relationship":"filer"},{"name":"SBC AI Longevity Innovation Inc.","relationship":"subsidiary"},{"name":"Cantor Fitzgerald Hong Kong","relationship":"forum host"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-12T13:00:06.950Z","global_importance":8,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"conference-appearance-notice","issuerAuthored":true}},"durationMs":5617,"modelName":"glm-5.3-flashx"}}